Tasso and development partner GenTegra win a $2.9 million grant from the U.S. Defense Advanced Research Projects Agency to continue their work on an integrated blood-sampling device.
Tasso said it won a $2.9 million grant from the U.S. Defense Advanced Research Projects Agency to continue work on an integrated blood-sampling device that can be used in war zones.
The grant to Tasso and development partner GenTegra was awarded based on progress the companies have made under a previously issued Phase II SBIR contract, Madison, Wis.-based Tasso said.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1CUwEGp
Cap comentari:
Publica un comentari a l'entrada